Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease

D. R. Wong*, M. J. H. Coenen, L. J. J. Derijks, S. H. Vermeulen, C. J. van Marrewijk, O. H. Klungel, H. Scheffer, B. Franke, H. -J. Guchelaar, D. J. de Jong, L. G. J. B. Engels, A. L. M. Verbeek, TOPIC Recruitment Team, Ad Masclee, P. M. Hooymans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)391-402
Number of pages12
JournalAlimentary Pharmacology & Therapeutics
Volume45
Issue number3
DOIs
Publication statusPublished - Feb 2017

Keywords

  • INDUCED LIVER-INJURY
  • S-METHYLTRANSFERASE ACTIVITY
  • AZATHIOPRINE
  • THERAPY
  • PHARMACOGENETICS
  • 6-MERCAPTOPURINE
  • MERCAPTOPURINE
  • 6-THIOGUANINE
  • PHARMACOKINETICS
  • ALLOPURINOL

Cite this

Wong, D. R., Coenen, M. J. H., Derijks, L. J. J., Vermeulen, S. H., van Marrewijk, C. J., Klungel, O. H., Scheffer, H., Franke, B., Guchelaar, H. -J., de Jong, D. J., Engels, L. G. J. B., Verbeek, A. L. M., TOPIC Recruitment Team, Masclee, A., & Hooymans, P. M. (2017). Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 45(3), 391-402. https://doi.org/10.1111/apt.13879